Follow us on:

Linkedin Facebook

Ilika Stereax device sales don’t have to wait till end of approval period (VIDEO)

Ilika plc (LON:IKA) CEO Graeme Purdy joins DirectorsTalk Interviews to discuss an update its on trading, Stereax® manufacturing, and Goliath product development.

Graeme addresses some concerns around the weighting now to medical devices where commercial sales are set to commence at the end of the (H2/2023) period, the visible lack of contracts, the interest Ilika is getting for Goliath, its strategic partners and whether it would it be better to complete the scale up and then look to spin or sell that part of the business.

Ilika is a pioneer in solid state battery technology, enabling solutions for applications such as Industrial IoT, MedTech, EV and Consumer Electronics.

Find more news, interviews, share price & company profile here for:

Share this interview

Twitter
LinkedIn
Facebook
Email
WhatsApp
Ilika Stereax device sales don’t have to wait till end of approval period (VIDEO)

Other Interviews

More News

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.